Michail ignatiadis
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Michail ignatiadis
Jun 14, 2024, 21:00 |
Blog
Michail Ignatiadis: Humble to have led this EBCC14 manifesto
Quoting Michail Ignatiadis, Director of Breast Medical Oncology Clinic and Program, Jules Bordet Institute, on…
Sep 15, 2023, 18:51 |
Blog
Michail Ignatiadis: Join us tomorrow with Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib
Quoting Michail Ignatiadis, Director of Breast Medical Oncology Clinic & Program, Jules Bordet Institute, on…
All:
2
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube